Post by BioDuro

Cyclic peptides are reshaping drug discovery by combining the specificity of larger molecules with improved permeability and cost efficiency compared to antibodies. Join Dr. Dongdong Wang, 𝗖𝗼-𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁 𝗼𝗳 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗼𝗳 Atombeat Inc. for a exploring a structured, methodical deep dive into cyclic peptide discovery powered by AI, including computational approaches for peptide design and generation. 𝗩𝗣 𝗮𝗻𝗱 𝗛𝗲𝗮𝗱 𝗼𝗳 𝗣𝗲𝗽𝘁𝗶𝗱𝗲 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺 𝗮𝘁 𝗕𝗶𝗼𝗗𝘂𝗿𝗼, Dr. Fengping Xiao, will also share the translational challenge of moving from AI-designed peptides to real-world validated molecules, and how BioDuro bridges this gap with rapid synthesis and direct-to-biology screening without purification to improve efficiency in both time and cost. This webinar will bring together AI-driven design and experimental validation to advance cyclic peptide discovery from concept to real-world application. 👉 Register now: https://lnkd.in/eihY7Xc8 #DrugDiscovery #CyclicPeptides # AIinDrugDiscovery #Atombeat #BioDuro